Sector Expert: Daniel Carlson
Daniel Carlson is the founder and managing member of Tailwinds Research Group and its parent company DFC Advisory Services, which is a licensed registered investment advisor (CRD # 297209). Tailwinds is a microcap focused research company that provides research on and consults to over 20 emerging growth companies in the technology and life sciences arenas. DFC Advisory Services is an RIA that manages money dedicated to investing in the companies covered by Tailwinds. For more information on these two companies and their track record, please see www.tailwindsresearch.com. Prior to founding these two entities, Dan spent many years working with small public companies, having been CFO of two public companies and helping finance many others. A 1989 graduate from Tufts University with a degree in Economics, Danís formative years in business were spent as an equity trader, first on the Pacific Coast Stock Exchange then on the buyside at several multi-billion dollar firms.
Companies Commented On
- Allergan Inc.
- Anixa Biosciences Inc.
- Atomera Inc.
- Bioasis Technologies Inc.
- Catasys Inc.
- FTE Networks Inc.
- Harrow Health Inc.
- Imprimis Pharmaceuticals Inc.
- ITUS Corp.
- Patriot One Technologies Inc.
- RumbleOn Inc.
- Summit Wireless Inc.
- Vicor Corp.
Daniel Carlson of Tailwinds Research examines the implications of correspondence with the regulatory agency as the company advances its lead candidate addressing brain cancer.
When Will the ATOM Bomb Launch? (6/1/19)
Investment advisor Daniel Carlson makes his case for why investors should have no fear of losing out on this technology company.
Sector expert Daniel Carlson offers his take on the recent jury decision, calling it "very positive."